Ka Dua Empat is primarily engaged in pharmaceuticals activity. Its headquarters is located in D.I. Yogyakarta. The company was founded in 2010. Ka Dua Empat, a dynamic player in the Indonesian pharmaceutical industry, was founded by a group of visionary entrepreneurs committed to enhancing healthcare accessibility and quality. The company focuses on the development, manufacturing, and distribution of a wide range of pharmaceutical products, including over-the-counter medications, prescription drugs, and health supplements. With a strong local presence, Ka Dua Empat operates several branches across major cities in Indonesia, ensuring a robust distribution network that caters to both urban and rural areas. The company is dedicated to expanding its geographical footprint and is exploring opportunities to enter international markets, particularly in Southeast Asia. Ka Dua Empat's product portfolio includes well-known brands that are trusted by healthcare professionals and consumers alike. The company is committed to innovation and invests significantly in research and development to introduce new and effective healthcare solutions. In collaboration with leading research institutions and healthcare organizations, Ka Dua Empat is involved in various joint ventures and partnerships aimed at advancing pharmaceutical research and development. The company is also an active member of several industry associations, contributing to the growth and development of the pharmaceutical sector in Indonesia. Ka Dua Empat's mission is to improve the quality of life through accessible and affordable healthcare solutions. The company envisions becoming a leading pharmaceutical company in the region, driven by a commitment to excellence, innovation, and social responsibility.
Headquarters
RT 018 RW 05
Yogyakarta; Yogyakarta;
Postal Code: 55162
Contact Details: Purchase the PT Ka Dua Empat report to view the information.
Website: http://www.k24.co.id
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service